BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18451703)

  • 1. Cortical pathology in multiple sclerosis.
    Stadelmann C; Albert M; Wegner C; Brück W
    Curr Opin Neurol; 2008 Jun; 21(3):229-34. PubMed ID: 18451703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination.
    Merkler D; Ernsting T; Kerschensteiner M; Brück W; Stadelmann C
    Brain; 2006 Aug; 129(Pt 8):1972-83. PubMed ID: 16714315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical lesion load associates with progression of disability in multiple sclerosis.
    Calabrese M; Poretto V; Favaretto A; Alessio S; Bernardi V; Romualdi C; Rinaldi F; Perini P; Gallo P
    Brain; 2012 Oct; 135(Pt 10):2952-61. PubMed ID: 23065788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histopathology of grey matter demyelination in multiple sclerosis.
    Bø L
    Acta Neurol Scand Suppl; 2009; (189):51-7. PubMed ID: 19566500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoinflammatory grey matter lesions in humans: cortical encephalitis, clinical disorders, experimental models.
    Junker A; Brück W
    Curr Opin Neurol; 2012 Jun; 25(3):349-57. PubMed ID: 22543404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grey matter pathology in multiple sclerosis.
    Bö L; Geurts JJ; Mörk SJ; van der Valk P
    Acta Neurol Scand Suppl; 2006; 183():48-50. PubMed ID: 16637929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
    Kutzelnigg A; Lucchinetti CF; Stadelmann C; Brück W; Rauschka H; Bergmann M; Schmidbauer M; Parisi JE; Lassmann H
    Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.
    Silvestroff L; Bartucci S; Pasquini J; Franco P
    Exp Neurol; 2012 May; 235(1):357-67. PubMed ID: 22421533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
    Kooi EJ; Geurts JJ; van Horssen J; Bø L; van der Valk P
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):1021-8. PubMed ID: 19680141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.
    Clarner T; Diederichs F; Berger K; Denecke B; Gan L; van der Valk P; Beyer C; Amor S; Kipp M
    Glia; 2012 Oct; 60(10):1468-80. PubMed ID: 22689449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
    Vrenken H; Geurts JJ
    Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
    Gardner C; Magliozzi R; Durrenberger PF; Howell OW; Rundle J; Reynolds R
    Brain; 2013 Dec; 136(Pt 12):3596-608. PubMed ID: 24176976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical pathology and cognitive impairment in multiple sclerosis.
    Calabrese M; Rinaldi F; Grossi P; Gallo P
    Expert Rev Neurother; 2011 Mar; 11(3):425-32. PubMed ID: 21375447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
    Chard D; Miller D
    J Neurol Sci; 2009 Jul; 282(1-2):5-11. PubMed ID: 19201002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.
    De Keyser J; Steen C; Mostert JP; Koch MW
    J Cereb Blood Flow Metab; 2008 Oct; 28(10):1645-51. PubMed ID: 18594554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limb ataxia originating from peri-central sulcus demyelinating lesion in multiple sclerosis.
    Karmon Y; Morrow SA; Weinstock A; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2012 Sep; 320(1-2):136-40. PubMed ID: 22698481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical imaging in multiple sclerosis: recent findings and 'grand challenges'.
    Daams M; Geurts JJ; Barkhof F
    Curr Opin Neurol; 2013 Aug; 26(4):345-52. PubMed ID: 23812306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
    Trapp BD; Vignos M; Dudman J; Chang A; Fisher E; Staugaitis SM; Battapady H; Mork S; Ontaneda D; Jones SE; Fox RJ; Chen J; Nakamura K; Rudick RA
    Lancet Neurol; 2018 Oct; 17(10):870-884. PubMed ID: 30143361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preactive lesions in multiple sclerosis.
    van der Valk P; Amor S
    Curr Opin Neurol; 2009 Jun; 22(3):207-13. PubMed ID: 19417567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.